Imatinib vs Levodopa

## Imatinib vs Levodopa: Overview

This comparison examines the pharmacological differences between **Imatinib** and **Levodopa**.

## Mechanism of Action

**Imatinib**: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

**Levodopa**: Metabolic precursor of dopamine that crosses the BBB.

## Pharmacokinetics

**Half-life**: Imatinib — 18 hours; Levodopa — 1.5 hours.

## Chemical Properties

**Molecular Formula**: Imatinib — C29H31N7O; Levodopa — C9H11NO4.

**Molecular Weight**: Imatinib — 493.6030 g/mol; Levodopa — 197.1880 g/mol.

**Type**: Imatinib — Small molecule; Levodopa — Small molecule.